CHARLES SCHWAB INVESTMENT MANAGEMENT INC - EIGER BIOPHARMACEUTICALS INC ownership

EIGER BIOPHARMACEUTICALS INC's ticker is EIGR and the CUSIP is 28249U105. A total of 93 filers reported holding EIGER BIOPHARMACEUTICALS INC in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
CHARLES SCHWAB INVESTMENT MANAGEMENT INC ownership history of EIGER BIOPHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$10,198
-56.7%
33,4360.0%0.00%
Q2 2023$23,539
-72.6%
33,436
-65.1%
0.00%
Q1 2023$85,958
-35.1%
95,839
-14.7%
0.00%
Q4 2022$132,533
-83.8%
112,316
+3.5%
0.00%
Q3 2022$818,000
+21.9%
108,528
+1.9%
0.00%
Q2 2022$671,000
-9.0%
106,502
+20.1%
0.00%
Q1 2022$737,000
+63.4%
88,711
+2.3%
0.00%
Q4 2021$451,000
-22.2%
86,7580.0%0.00%
Q3 2021$580,000
-18.1%
86,758
+4.5%
0.00%
Q2 2021$708,000
+4.0%
83,031
+7.9%
0.00%
Q1 2021$681,000
-25.3%
76,931
+3.7%
0.00%
Q4 2020$912,000
+66.1%
74,188
+10.1%
0.00%
Q3 2020$549,000
-7.4%
67,387
+9.2%
0.00%
Q2 2020$593,000
+45.3%
61,701
+3.0%
0.00%
Q1 2020$408,000
-55.0%
59,879
-1.5%
0.00%
Q4 2019$906,000
+65.6%
60,803
+13.9%
0.00%
Q3 2019$547,000
-3.4%
53,3600.0%0.00%
Q2 2019$566,00053,3600.00%
Other shareholders
EIGER BIOPHARMACEUTICALS INC shareholders Q1 2020
NameSharesValueWeighting ↓
Simplify Asset Management Inc. 2,700,000$823,5000.09%
683 Capital Management, LLC 2,650,000$808,2500.06%
GSA CAPITAL PARTNERS LLP 355,867$1090.01%
RBF Capital, LLC 391,265$119,3360.01%
UBS OCONNOR LLC 393,975$120,1620.00%
XTX Topco Ltd 15,597$4,7570.00%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 106,700$32,5440.00%
AMERIPRISE FINANCIAL INC 8,592,471$2,620,7040.00%
DRW Securities, LLC 120,365$370.00%
DFPG INVESTMENTS, LLC 32,430$10,8960.00%
View complete list of EIGER BIOPHARMACEUTICALS INC shareholders